US · Technology · Scientific & Technical Instruments
EPS came in at 1.83 against a street estimate of 1.39 — a beat of 31.5%.
Analysts rate Mesa Laboratories Inc a buy (2 buy, 1 hold, 1 sell out of 4) with an average price target of $112.00.
| Fund | Stake |
|---|---|
| Long Path Partners, LP | 7.25% |
| BlackRock Inc | 7.04% |
| Boston Partners Global Investors, Inc | 4.80% |
| Select Equity Group LP | 4.22% |
| Vanguard Capital Management, LLC | 4.16% |
| Ranger Investment Management LP | 3.63% |
| AQR Capital Management LLC | 3.05% |
| Morgan Stanley - Brokerage Accounts | 2.90% |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Mesa Laboratories Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.